KTRA Historical PE Ratio image   This KTRA PE ratio history page last updated 1/12/2023
KTRA PE History Chart
PeriodPriceGAAPTTMPE
Q1 2023
11/9/2022
4.55-3.50-18.50NA
Q4 2022
9/27/2022
5.50-3.50-27.50NA
Q3 2022
5/13/2022
9.40-5.50-30.50NA
Q2 2022
2/11/2022
22.50-6.00-36.50NA
Q1 2022
11/15/2021
43.75-12.50-41.50NA
Q4 2021
9/28/2021
43.35-6.50-47.00NA
Q3 2021
5/14/2021
64.00-11.50-23.00NA
Q2 2021
2/12/2021
124.00-11.00-20.00NA
Q1 2021
11/13/2020
76.00-18.00-16.50NA
Q4 2020
9/21/2020
72.5017.50-9.00NA
Q3 2020
5/13/2020
32.70-8.50-71.00NA
Q2 2020
2/13/2020
27.50-7.50-96.00NA
Q1 2020
11/14/2019
39.20-10.50-128.50NA
Q4 2019
9/10/2019
31.20-44.50-163.00NA
Q3 2019
5/15/2019
110.50-33.50-168.50NA
Q2 2019
2/12/2019
19.50-40.00-200.00NA
Q1 2019
11/14/2018
30.50-45.00-230.00NA
Q4 2018
9/24/2018
41.00-50.00-275.00NA
Q3 2018
5/17/2018
48.60-65.00-325.00NA
Q2 2018
2/14/2018
68.00-70.00-350.00NA
Q1 2018
11/13/2017
40.35-90.00NANA
Q4 2017
9/28/2017
42.25-100.00NANA
Q3 2017
5/18/2017
121.00-90.00NANA
KTRA Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2023
11/9/2022
4.55-3.50-14.00NA
Q4 2022
9/27/2022
5.50-3.50-14.00NA
Q3 2022
5/13/2022
9.40-5.50-22.00NA
Q2 2022
2/11/2022
22.50-6.00-24.00NA
Q1 2022
11/15/2021
43.75-12.50-50.00NA
Q4 2021
9/28/2021
43.35-6.50-26.00NA
Q3 2021
5/14/2021
64.00-11.50-46.00NA
Q2 2021
2/12/2021
124.00-11.00-44.00NA
Q1 2021
11/13/2020
76.00-18.00-72.00NA
Q4 2020
9/21/2020
72.5017.5070.001.0
Q3 2020
5/13/2020
32.70-8.50-34.00NA
Q2 2020
2/13/2020
27.50-7.50-30.00NA
Q1 2020
11/14/2019
39.20-10.50-42.00NA
Q4 2019
9/10/2019
31.20-44.50-178.00NA
Q3 2019
5/15/2019
110.50-33.50-134.00NA
Q2 2019
2/12/2019
19.50-40.00-160.00NA
Q1 2019
11/14/2018
30.50-45.00-180.00NA
Q4 2018
9/24/2018
41.00-50.00-200.00NA
Q3 2018
5/17/2018
48.60-65.00-260.00NA
Q2 2018
2/14/2018
68.00-70.00-280.00NA
Q1 2018
11/13/2017
40.35-90.00-360.00NA
Q4 2017
9/28/2017
42.25-100.00-400.00NA
Q3 2017
5/18/2017
121.00-90.00-360.00NA
Quotes delayed 20 minutes

Email EnvelopeFree KTRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Kintara Therapeutics (KTRA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

KTTA PE Ratio History
KURA PE Ratio History
KYMR PE Ratio History
KZR PE Ratio History
LAB PE Ratio History
LABP PE Ratio History
LBPH PE Ratio History
LCI PE Ratio History
LFST PE Ratio History
LGND PE Ratio History
On this page we presented the KTRA PE Ratio History information for Kintara Therapeutics' stock. The average KTRA PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average KTRA PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this KTRA PE ratio history result, against the recent PE: when this page was posted on 1/11/2023, the most recent closing price for KTRA had been 7.87, and the most recent quarterly earnings result, annualized, was 70. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent KTRA PE on 1/11/2023 based on annualized quarterly EPS was 0.1. Based on KTRA's history, that recent PE is low relative to the historical average, with the recent PE 90.0% lower than the historical average PE across our data set for Kintara Therapeutics.

For self directed investors doing their due diligence on KTRA or any other given stock, valuation analysis for KTRA can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Kintara Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for KTRA. Thanks for visiting, and the next time you need to research KTRA PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: ZHNE Insider Buying, CMPR Price Target, Funds Holding XHYE.

 

KTRA PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.